Human herpesvirus 8: II. Pathogenic role and sensitivity to antiviral drugs;L'herpesvirus humain 8 (HHV8): II. Role pathogene et sensibilite aux antiviraux

Annales de Biologie Clinique

Volumn 57, Issue 1, 1999, Pages 19-28

  Boulanger, E ^a  

^a Hopital Salisbury   (France)

Author keywords

Herpesvirus; HHV8; Kaposi's sarcoma; KSHV; Primary effusion lymphoma

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; CELL PROLIFERATION; DRUG SENSITIVITY; HERPES; HUMAN; HUMAN HERPESVIRUS 8; IN VITRO STUDY; KAPOSI SARCOMA; LYMPHOID CELL; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PREVENTION; REVIEW; B CELL LYMPHOMA; DRUG EFFECT; HERPES VIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOPROLIFERATIVE DISORDERS; SARCOMA, KAPOSI;

EID: 0032608078     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma. J Am Acad Dermatol 1993 ; 28 : 371-95.
2. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995 ; 268 : 582-3.
3. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995 ; 332 : 1181-5.
4. Boshoff C, Whitby D, Hatziinannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995 ; 345 : 1043-4.
5. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995 ; 345 : 759-61.
6. Foreman KE, Bacon PE, Hsi ED, Nickoloff BJ. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two Aids-related neoplasms : Kaposi's sarcoma and body cavity lymphoma. J Clin Invest 1997 ; 99 : 2971-8.
7. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997 ; 71 : 715-9.
8. Decker LL, Shankar P, Khan G, et al. The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996 ; 184 : 283-8.
9. Orenstein JM, Alkan S, Blauvelt A, et al. Visualization of human herpesvirus 8 in Kaposi's sarcoma by light and transmission electron microscopy. Aids 1997 ; 11 : F35-45.
10. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995 ; 346 : 799-802.
11. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995 ; 332 : 1186-91.
12. Nador RG, Cesarman E, Knowles DM, Said JW. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med 1995 ; 333 : 943.
13. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women : report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996 ; 88 : 3124-8.
14. Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman's disease in HIV infection : a clinical and pathological study of 20 patients. AIDS 1996 ; 10 : 61-7.
15. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995 ; 86 : 1276-80.
16. Gessain A, Sudaka A, Brière J, et al. Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease : is there any relevant association in non-human immunodeficiency virus-infected patients ? Blood 1996 ; 87 : 414-6.
17. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996 ; 57 : 3903-9.
18. Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 1997 ; 80 : 788-97.
19. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like sequences in Aids-associated Kaposi's sarcoma. Science 1994 ; 266 : 1865-9.
20. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 1998 ; 338 : 1585-90.
21. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997 ; 276 : 1851-4.
22. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995 ; 345 : 1339-40.
23. Di Alberti L, Piattelli A, Artese L, et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997 ; 350 : 1655-61.
24. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996 ; 335 : 233-41.
25. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and natural history of human herpesvirus 8 infection. N Engl J Med 1998 ; 338 : 948-53.
26. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis factor. Nature 1998 ; 391 : 86-9.
27. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997 ; 15 : 1979-85.
28. Herndier BC, Werner A, Arnstein P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals AIDS 1994 ; 8 : 575-81.
29. Foreman KE, Friborg J, Kong WP, et al. Propagation of a human herpesvirus from Aids-associated Kaposi's sarcoma. N Engl J Med 1997 ; 336 : 163-71.
30. Gluckman E, Parquet N, Scieux C, et al. KS-associated herpesvirus-like DNA sequences after allogeneic bone marrow transplantation. Lancet 1995 ; 346 : 1558.
31. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV1 Tat protein in induction of Kaposi's sarcoma. Nature 1994 ; 371 : 674-80.
32. Harrington W, Sieczkowski L, Sosa C, et al. Activation of HHV-8 by HIV-1 tat. Lancet 1997 ; 349 : 774-5.
33. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995 ; 375 : 64-8.
34. Said JW, Chien K, Takeuchi S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) in primary effusion lymphoma : ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996 ; 87 : 4937-43.
35. Picchio GR, Sabbe RE, Gulizia RJ, McGrath M, Herndier BG, Mosier DE. The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to human peripheral blood mononuclear cell graft. Virology 1997 ; 238 : 22-9.
36. + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 1998 ; 91 : 1671-9.
37. Asou H, Said SJ, Yang R, et al. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 1998 ; 91 : 2475-81.
38. Gaidano G, Pastore C, Gloghini A, et al. Microsatellite instability in KSHV/HHV-8 positive body-cavity-based lymphoma. Hum Pathol 1997 ; 28 : 748-50.
39. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994 ; 26 : 749-52.
40. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma : data from the multicenter Aids cohort study. J Infect Dis 1996 ; 173 : 1477-80.
41. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. Aids-associated Kaposi's sarcoma. Science 1995 ; 267 : 1078-9.
42. Costagliola D, Mary-Krause M. Can antiviral agents decrease the occurrence of Kaposi's sarcoma ? Lancet 1995 ; 346 : 578.
43. Kedes DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997 ; 99 : 2082-6.
44. Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997 ; 11 : 1327-32.
45. Neyts J, de Clercq E. Antiviral drug susceptibility of human herpesvirus 8. Antimicrobial Agents Chemother 1997 ; 41 : 2754-6.
46. Burdick AE, Carmichael C, Rady PL, Tyring SK, Badiavas E. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy. J Am Acad Dermatol 1997 ; 37 : 648-9.
47. Rizzieri DA, Liu J, Traweek ST, Miralles GD. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 1997 ; 349 : 775-6.
48. Dupin N, Krivine A, Calvez V, Gorin I, Franck N, Escande JP. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient. AIDS 1997 ; 11 : 1400-1.